To provide nursing education to the cancer patients so that chemotherapy related side effects can be minimised.
Phase 1
- Conditions
- Health Condition 1: null- Patients on chemotherapy
- Registration Number
- CTRI/2018/07/014912
- Lead Sponsor
- Pramod Kumar Nagar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients equal to less than 16 years of age
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in the Prevalence of manifestations of neutropenia: <br/ ><br>Fever <br/ ><br> Fatigue <br/ ><br> Nausea/vomiting <br/ ><br> Diarrhoea <br/ ><br> Anorexia <br/ ><br> Weight loss <br/ ><br> Alopecia <br/ ><br> Oral mucositis <br/ ><br> <br/ ><br>Timepoint: 15 July 2018 to 30 September 2018 <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method Decreased hospital admission due to chemotherapy induced neutropenia and <br/ ><br>reduced the cost of treatmentTimepoint: After completion of 1 ,2 ,3 cycle of chemotherapy.15 July 2018 to 30 September 2018